Orbimed Advisors LLC’s Myriad Genetics Inc Position
Does Orbimed Advisors LLC own Myriad Genetics Inc (MYGN)? Yes — 125.00M shares worth $123M (+2.44% of its 13F portfolio) as of Q1 2026.
Position Value
$123M
Q1 2026
Shares
125.00M
% of Portfolio
+2.44%
Quarters Held
1
currently held
Position History MYGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 125.00M | $123M | +2.44% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of MYGN.